Aug 24, 2026 07:00AM
Jul 24, 2026 08:31AM
Jul 24, 2026 08:30AM
Jul 22, 2026 09:00AM
Jul 15, 2026 01:01AM
Jul 15, 2026 01:00AM
Jul 2, 2026 01:10AM Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
Jun 30, 2026 01:09AM
Jun 30, 2026 01:09AM
Jun 18, 2026 01:00AM
Jun 18, 2026 01:00AM
Jun 11, 2026 01:05AM
Jun 11, 2026 01:05AM
Jun 2, 2026 07:00AM U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for Itovebi™ (inavolisib) to Identify Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer wit
Jun 2, 2026 01:05AM
May 19, 2026 01:05AM
May 19, 2026 01:05AM
May 15, 2026 12:45PM
May 15, 2026 12:45PM
Apr 30, 2026 01:00AM
Apr 24, 2026 02:49AM Morgan Stanley Upgrades Roche Holding (ROG:SW) (RHHBY) to Equalweight
Apr 22, 2026 08:30AM
Apr 21, 2026 07:15PM
Apr 21, 2026 11:45AM
Apr 21, 2026 01:00AM
Apr 16, 2026 07:00AM
Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories
Mar 19, 2026 02:11PM
Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM
Mar 2, 2026 01:10AM
Feb 20, 2026 02:00AM
Feb 20, 2026 02:00AM FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
Feb 20, 2026 01:05AM
Feb 16, 2026 01:00AM
Feb 7, 2026 03:40PM
Dec 22, 2025 01:01AM
Dec 22, 2025 01:00AM
Dec 16, 2025 08:30AM
Dec 8, 2025 04:30PM Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
Nov 10, 2025 01:10AM
Nov 3, 2025 09:00AM
Nov 3, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 23, 2025 09:00AM
Oct 20, 2025 01:05AM
Oct 20, 2025 01:01AM FDA approves Genentech's Gazyva for lupus nephritis treatment
Oct 20, 2025 01:00AM

329,194 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All